NIH-funded research R03 grant

A new implant for long-lasting pain relief without addiction

Official title: In situ forming implant drug delivery for non-addictive post-operative analgesia

Funded at University of Kentucky · NIH-11117284 · Data updated 2026-11-12

This study is testing a new implant that can provide pain relief directly where you had surgery, helping to manage your pain for up to a week without relying on traditional painkillers, which can be addictive, especially for patients having oral facial surgery.

More Analgesia research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startJanuary 10, 2025
Project endDecember 31, 2026
Funding year2025
Award (this year)$75,007
NIH project number1R03EB037115-01
Project IDNIH-11117284 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing oral facial surgery who require effective postoperative pain management.

Less likely to help

Patients who do not undergo surgical procedures or those with chronic pain conditions unrelated to surgery may not benefit from this research.

What this research studies

This research investigates a novel implant that can deliver pain relief medication directly at the site of surgery, potentially extending pain management beyond the current 72-hour limit. The implant is designed to release a local anesthetic called bupivacaine in a controlled manner, which could help manage pain for up to 168 hours after surgery. By using a special polymer system, the implant aims to minimize the risk of addiction associated with traditional opioid pain medications. Patients receiving oral facial surgery may particularly benefit from this innovative approach to postoperative pain management.

Why it matters

Potential benefit: If successful, this research could provide patients with effective pain relief after surgery without the risk of addiction associated with opioids.

How similar studies have gone: While the approach of using in situ forming implants is promising, it is still relatively novel and has not been widely tested in the context of postoperative analgesia.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Givens Rassoolkhani, Brittany Estelle — University of Kentucky
  • Study coordinator: Givens Rassoolkhani, Brittany Estelle

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.